This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery

Sponsored by Samsung Medical Center

About this trial

Last updated 15 years ago

Study ID

2009-08-089

Status

Unknown

Type

Interventional

Phase

Phase 3

Placebo

No

Accepting

20 to 75 Years
All Sexes

Trial Timing

Ended 15 years ago

What is this trial about?

Ultrasonic coagulating shears are made for performing for cutting and hemostasis at once during operation. It was proved that a laparoscopic gastric resection showed significantly shorter operative time and less work load distribution, and more stability of bleeding than before an introduction of ultrasonic coagulating shears . In an open gastric cancer surgery, ultrasonic coagulating shears have been often used for lymph node dissection or cutting of small vessels in some hospitals in Korea. However its usefulness or effectiveness has not been fully proved. There was only one report about using ultrasonic coagulating shears in open gastrectomy. The report contained small number of subjects and surgical procedures were different from the investigators. The investigators expect to reduce operative time and blood loss with ultrasonic coagulating shears. Ultrasonic coagulating shears will also enable us to dissect lymph node with closure of lymphatics. This may reduce the amount of drainage fluid from peritoneal cavity and shorten the removal time of a drain, which will also shorten the hospital stay. The objective of this study is to evaluate the safety and benefit of ultrasonic coagulating shears in open gastrectomy including usefulness and effectiveness by a randomized controlled, prospective study.

What are the participation requirements?

Inclusion Criteria

* Patients with the diagnosis of gastric cancer

* The patient who agrees to participate in this study by signing the informed consent form

Exclusion Criteria

* The patient who refuse to participate in this study

* Have simultaneously other cancer

* Underwent cancer therapy at past time

* Have bleeding disorder, coagulation disorder, chronic disease (e.g.heart failure, cardiovascular disease, active hepatitis)

* Have a previous upper gastrointestinal surgery